Literature DB >> 16702107

Differences in beta-glucan levels in culture supernatants of a variety of fungi.

Zekaver Odabasi1, Victor L Paetznick, Jose R Rodriguez, Enuo Chen, Michael R McGinnis, Luis Ostrosky-Zeichner.   

Abstract

(1-->3)-beta-d-glucan is a well known cell wall constituent of fungal isolates that can be detected by assays in vivo and in vitro. Previous studies have shown that different fungal isolates may show different levels of reactivity with an assay for beta glucan. In this study we evaluated the in vitro reactivity of 127 clinical fungal isolates belonging to 40 different genera, with the Glucatell assay. The majority of the fungal isolates released high levels of beta glucan. Beta glucan test reactivity appears to be species-specific and this may reflect the beta glucan content of the organism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16702107     DOI: 10.1080/13693780500474327

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  29 in total

1.  How to interpret serum levels of beta-glucan for the diagnosis of invasive fungal infections in adult high-risk hematology patients: optimal cut-off levels and confounding factors.

Authors:  H Hammarström; N Kondori; V Friman; C Wennerås
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-09       Impact factor: 3.267

2.  Invasive Scopulariopsis alboflavescens infection in patient with acute myeloid leukemia.

Authors:  Keiji Kurata; Sho Nishimura; Hiroya Ichikawa; Rina Sakai; Yu Mizutani; Kei Takenaka; Seiji Kakiuchi; Yoshiharu Miyata; Akihito Kitao; Kimikazu Yakushijin; Shinichiro Kawamoto; Katsuya Yamamoto; Mitsuhiro Ito; Hiroshi Matsuoka; Issei Tokimatsu; Katsuhiko Kamei; Hironobu Minami
Journal:  Int J Hematol       Date:  2018-07-09       Impact factor: 2.490

3.  Reactivity of (1-->3)-beta-d-glucan assay with commonly used intravenous antimicrobials.

Authors:  Francisco M Marty; Colleen M Lowry; Steven J Lempitski; David W Kubiak; Malcolm A Finkelman; Lindsey R Baden
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

4.  (1,3)-β-d-glucan in cerebrospinal fluid for diagnosis of fungal meningitis associated with contaminated methylprednisolone injections.

Authors:  Anurag N Malani; Bonita Singal; L Joseph Wheat; Ola Al Sous; Theresa A Summons; Michelle M Durkin; April C Pettit
Journal:  J Clin Microbiol       Date:  2014-12-24       Impact factor: 5.948

5.  Clinical performance of the (1,3)-β-D-glucan assay in early diagnosis of nosocomial Candida bloodstream infections.

Authors:  Valerio Del Bono; Emanuele Delfino; Elisa Furfaro; Malgorzata Mikulska; Elena Nicco; Paolo Bruzzi; Alessandra Mularoni; Matteo Bassetti; Claudio Viscoli
Journal:  Clin Vaccine Immunol       Date:  2011-10-12

6.  Reactivity of (1→3)-β-d-glucan assay in bacterial bloodstream infections.

Authors:  O Albert; D Toubas; C Strady; J Cousson; C Delmas; V Vernet; I Villena
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-10       Impact factor: 3.267

7.  Detection of (1-->3)-beta-D-glucan as an adjunct to diagnosis in a mixed population with uncommon proven invasive fungal diseases or with an unusual clinical presentation.

Authors:  María Soledad Cuétara; Almudena Alhambra; María Dolores Moragues; Ernesto González-Elorza; José Pontón; Amalia del Palacio
Journal:  Clin Vaccine Immunol       Date:  2009-01-21

Review 8.  Scedosporium Cell Wall: From Carbohydrate-Containing Structures to Host-Pathogen Interactions.

Authors:  Rodrigo Rollin-Pinheiro; Mariana Ingrid Dutra da Silva Xisto; Victor Pereira Rochetti; Eliana Barreto-Bergter
Journal:  Mycopathologia       Date:  2020-09-29       Impact factor: 2.574

9.  Immune recognition of Candida albicans beta-glucan by dectin-1.

Authors:  Neil A R Gow; Mihai G Netea; Carol A Munro; Gerben Ferwerda; Steven Bates; Héctor M Mora-Montes; Louise Walker; Trees Jansen; Liesbeth Jacobs; Vicky Tsoni; Gordon D Brown; Frank C Odds; Jos W M Van der Meer; Alistair J P Brown; Bart Jan Kullberg
Journal:  J Infect Dis       Date:  2007-10-31       Impact factor: 5.226

Review 10.  Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients.

Authors:  Georg Maschmeyer; Antje Haas; Oliver A Cornely
Journal:  Drugs       Date:  2007       Impact factor: 11.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.